Swiss - Delayed Quote ? CHF BB Biotech AG Ord (BION.SW) Follow Compare 39.00 +0.15 (+0.39%) As of 12:16 PM GMT+1. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Edison Issues Report on BB Biotech (BION) London, United Kingdom--(Newsfile Corp. - August 14, 2024) - Edison issues report on BB Biotech (SWX: BION).BB Biotech, a Switzerland-based investment company, targets long-term capital growth from biotechnology companies developing and marketing innovative drugs. At least 90% of the portfolio is held in listed companies, primarily those that already have products on the market or promising drug candidates in advanced stages of development. BION is benchmarked against the Nasdaq Biotech Index (i Newsfile ? 2 months ago BBAGF Performance Overview Trailing total returns as of 11/8/2024, which may include dividends or other distributions. Benchmark is MSCI WORLD Return BION.SW MSCI WORLD YTD -4.73% +19.38% 1-Year +3.90% +31.03% 3-Year -43.70% 0.00%